thiazolyl blue has been researched along with cyc 202 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agbottah, E; Barnett, A; de La Fuente, C; Gianella-Borradori, A; Kashanchi, F; Nekhai, S; Pumfery, A | 1 |
Hu, LY; Li, X; Wu, ZH; Xu, DQ | 1 |
2 other study(ies) available for thiazolyl blue and cyc 202
Article | Year |
---|---|
Antiviral activity of CYC202 in HIV-1-infected cells.
Topics: Antiretroviral Therapy, Highly Active; Antiviral Agents; Apoptosis; CDC2-CDC28 Kinases; Cell Cycle; Chromatin Immunoprecipitation; Cyclin E; Cyclin-Dependent Kinase 2; DNA Fragmentation; DNA, Viral; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Escherichia coli; Flow Cytometry; Genome, Viral; HIV-1; Humans; Immunoblotting; Inhibitory Concentration 50; Leukocytes, Mononuclear; Monocytes; Mutation; Phosphorylation; Purines; RNA Interference; RNA, Small Interfering; Roscovitine; Tetrazolium Salts; Thiazoles; Time Factors; Transcription, Genetic | 2005 |
A cell-based assay for screening spindle checkpoint inhibitors.
Topics: Antineoplastic Agents; Aurora Kinases; Blotting, Western; Cell Cycle; Cell Cycle Checkpoints; Cell Line; Coloring Agents; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Fluorescent Antibody Technique; HeLa Cells; High-Throughput Screening Assays; Humans; Mitotic Index; Nocodazole; Protein Serine-Threonine Kinases; Purines; Roscovitine; Spindle Apparatus; Tetrazolium Salts; Thiazoles | 2012 |